Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

Tushar MungleNandana DasSaikat PalManash Pratim GogoiParag DasNiharendu GharaDebjani GhoshRamandeep Singh AroraNickhill BhaktaVaskar SahaShekhar Krishnan

Published in: Cancer medicine (2022)

Risk-stratified approach to treat childhood ALL is very cost-effective for all categories in our setting. The cost for SR and IR patients is significantly reduced through decreased IP admissions for both, chemotherapy and non-chemotherapy reasons.

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
ejection fraction
newly diagnosed
locally advanced
squamous cell carcinoma
childhood cancer
young adults
patient reported
smoking cessation